Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma

Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma

Introduction: Transarterial chemoembolization (TACE) is the first-line treatment for patients with intermediate-stage hepatocellular carcinoma (HCC). For patients without an adequate response, current finding suggests that treatment with molecular target agents, approved for advanced stage, might pr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Joel Ferreira-Silva, Pedro Costa-Moreira, Helder Cardoso, Rodrigo Liberal, Pedro Pereira, Guilherme Macedo
Format: article
Langue:EN
Publié: Karger Publishers 2021
Sujets:
hepatocellular carcinoma
transarterial chemoembolization
child-pugh class
Diseases of the digestive system. Gastroenterology
RC799-869
Accès en ligne:https://doaj.org/article/530d888250444b439886496927e95d5c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/530d888250444b439886496927e95d5c

Documents similaires